Nektar Therapeutics
Closed
72.7 -2.59
Overview
Share price change
24h
Min
71.18
Max
72.7
Income | 4.3M -41M |
|---|---|
Sales | -730K 10M |
EPS | -1.23 |
Profit margin | -400.967 |
Employees | 63 |
EBITDA | -5.5M -42M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +97.78% upside |
Next Earnings | 5 Nov 2026 |
|---|
Market Cap | -13M 2.5B |
|---|---|
Previous open | 75.29 |
Previous close | 72.7 |
Nektar Therapeutics Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
97.78% upside
12 Months Forecast
Average 143.43 USD 97.78%
High 192 USD
Low 65 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$